Vaxxinity, Inc.(NASDAQ:VAXX) 
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease; UB-...
Website: http://www.vaxxinity.com
Founded: 2019
CEO: Mei Mei Hu
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-02-20
P
O 0.66
H 0.66
L 0.56
C 0.64
V 1,288,437
10EMA 0.64
20EMA 0.64
60EMA 0.64
120EMA 0.64
250EMA 0.64